This study, called LockeT II, is looking at a new way to close wounds after procedures like atrial fibrillation ablation (a treatment for an irregular heartbeat). Currently, doctors often use manual compression (holding pressure on the wound) which can mean long bed rest. This study compares manual compression to a device called LockeT. The LockeT device uses a suture (stitch) to apply pressure, aiming to achieve the same benefits as manual compression without needing a healthcare professional to hold pressure. The study wants to see how effective the LockeT device is at closing the wound within two days. You might be able to join if you are at least 18 years old and are having a procedure that requires a venous puncture, like atrial fibrillation ablation. The study is currently unclear on its recruitment status.

Study design

This is a single-center, randomized study, meaning participants are randomly assigned to either receive the LockeT device or manual compression. Approximately 110 patients will be enrolled.

What's involved

For participants assigned to the LockeT device, a healthcare professional will place the device with a suture above the wound for compression. The LockeT will be removed before you can walk around.

Compensation

Not stated in the trial record.

Follow-up

The effectiveness of the LockeT device will be measured at 2 days after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.